Menopause Flashcards

1
Q

Menopause

A

Cessation of menstruation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Climacteric (perimenopause)

A

The period around the menopause and at least the first year after it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Post-menopause

A

12 months of no period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Average age of onset of menopause in the uk

A

51

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Range of age of onset of menopause

A

48-52

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Premature menopause

A

Before 40 (1%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cause of menopause

A

Age - depletion of primordial follicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Causes of premature menopause

A

Idiopathic
Iatrogenic
Chromosomal (fragile X syndrome, FMR1)
Autoimmune
Others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mechanism of menopause

A

Ovaries depleted of follicles
Decline of oestrogen production
Gradual decline with fluctuation over a few years
Gradual rise of FSH and LH (lack of negative feedback mechanism)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the age of menopause decided by

A

Size of primordial pool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Problems associated with premature menopause

A

Increased risk of mortality
Risk of cognitive dysfunction
Heart disease
Mood and sexual disorders
Bone mineral density
Autoimmune and thyroid disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Short term symptoms of menopause

A

Vasomotor
Psychological
Urogenital
Skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Long term risks of menopause

A

Osteoporosis
Cardiovascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Vasomotor

A

Hot flushes
Sweats: mainly night
Palpitations
Headaches

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Psychological

A

Irritability
Lethargy
Emotional lability
Forgetfulness
Loss of libido
Loss of concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Urogenital

A

Vaginal dryness
Dyspareunia- due to dryness
Urethral syndrome - mainly later on in the absence of HRT

17
Q

Skin

A

Dryness of skin and hair
Brittle nails

18
Q

Osteoporosis

A

Decreased amount of bony tissue per unit volume of blood
Wrist, femoral neck and vertebrae
Bone remodelling is uncoupled
5% loss of trabecular bone per year

19
Q

Risk factors of osteoporosis

A

Race- European and Asian women
Nulliparity
Low body weight
Poor diet in childhood
Alcohol abuse
Heavy smoking
Steroids
Thyrotoxicosis, hyperparathyroidism, Cushing disease etc

20
Q

Cardiovascular disease- myocardial infarction, angina and cerebrovascular stroke

A

Equal risk to me by age 70
Cause unknown
Family history is a determinant factor
Other variables: obesity, diabetes

21
Q

Treatment of menopause

A

HRT
Sedatives and tranquillisers
Clonidine
Beta blockers
Maintaining pre-menopausal sexual activities
Calcium, vitamin D, calcitonin
Symptomatic treatment

22
Q

HRT- hormone replacement therapy

A

Oestrogen
Progesterone if uterus intact - to reduce risk of endometrial cancer
Different formats
Different doses

23
Q

HRT preparations

A

Oral
Skin patches
Vaginal cream
Skin cream
Nasal spray
Vaginal ring
Implants

24
Q

Long term risk of HRT

A

Cardiovascular (E):
- Slight increase in CVS (oral vs transdermal)
- IHD no increased risk but no benefit

Breast cancer (E + P vs E):
Increased by 2 per 1000 if taken for >5 years.
6/1000 for 10 years use.
12/1000 for 15 years use.

VTE (venous thromboembolism): 1-3 in 10,000 women in the first year.

Cancer:
Slight increase in ovarian cancer (seq. HRT).
Endometrial Cancer: if unopposed E2.

25
Q

Contraindications of HRT

A

Abnormal liver function
Obstetric cholestasis
Thromboembolic disease
Congenital dist. Of lipid metabolism
Hormone dependent tumours
Sickle cell anaemia

26
Q

Individualised symptomatic treatment

A

CBT
Testosterone
Local steroids - monitoring of ET
Complementary therapies
Lifestyle
Monitoring